We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$441M
AUM Growth
+$91.2M
Cap. Flow
+$74.5M
Cap. Flow %
16.9%
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$15.4M
2
STLA icon
Stellantis
STLA
+$9.9M
3
ALC icon
Alcon
ALC
+$7.77M
4
AMZN icon
Amazon
AMZN
+$6.64M
5
RACE icon
Ferrari
RACE
+$5.26M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.26%
2 Technology 13.6%
3 Financials 12.86%
4 Healthcare 10.91%
5 Industrials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYG icon
101
iShares US Financial Services ETF
IYG
$2.13B
$894K 0.2%
14,388
+12,528
+674% +$765K
ACM icon
102
Aecom
ACM
$9.07B
$889K 0.2%
+14,217
New +$929K
KR icon
103
Kroger
KR
$34.8B
$825K 0.19%
21,679
+21,650
+74,655% +$815K
JNPR
104
DELISTED
Juniper Networks
JNPR
$821K 0.19%
29,914
+8,062
+37% +$215K
GS icon
105
Goldman Sachs
GS
$313B
$805K 0.18%
2,141
+838
+64% +$300K
ECHO
106
EchoStar
ECHO
$25.5B
$797K 0.18%
34,062
+33,950
+30,313% +$871K
MET icon
107
MetLife
MET
$61B
$796K 0.18%
13,570
+520
+4% +$33K
ASHR icon
108
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
$795K 0.18%
19,894
+14,028
+239% +$559K
XPOA
109
DELISTED
DPCM Capital, Inc.
XPOA
$790K 0.18%
80,000
ABNB icon
110
Airbnb
ABNB
$83.7B
$780K 0.18%
+5,441
New +$854K
CRBN icon
111
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.12B
$759K 0.17%
4,523
+3,688
+442% +$603K
VFC icon
112
VF Corp
VFC
$6.68B
$758K 0.17%
9,267
+8,604
+1,298% +$717K
CMI icon
113
Cummins
CMI
$91.7B
$755K 0.17%
3,127
+1,118
+56% +$286K
XIFR
114
XPLR Infrastructure LP
XIFR
$1.18B
$754K 0.17%
10,117
+9,522
+1,600% +$681K
SPAQ.U
115
DELISTED
Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo
SPAQ.U
$753K 0.17%
75,000
DGX icon
116
Quest Diagnostics
DGX
$25.1B
$750K 0.17%
5,554
-356
-6% -$46.6K
PWR icon
117
Quanta Services
PWR
$93.9B
$750K 0.17%
8,356
+6,951
+495% +$653K
UBS icon
118
PUT
UBS Group
UBS
$170B
$742K 0.17%
14,543
-8,083
-36% -$128K
AXP icon
119
American Express
AXP
$223B
$741K 0.17%
+4,292
New +$672K
MTZ icon
120
MasTec
MTZ
$26.7B
$740K 0.17%
7,137
+5,980
+517% +$649K
PG icon
121
Procter & Gamble
PG
$343B
$734K 0.17%
5,362
-656
-11% -$88.8K
GWW icon
122
W.W. Grainger
GWW
$65.3B
$729K 0.17%
1,601
+1,595
+26,583% +$704K
T icon
123
AT&T
T
$165B
$716K 0.16%
33,530
-89,711
-73% -$2.04M
ETN icon
124
Eaton
ETN
$157B
$712K 0.16%
4,620
+35
+0.8% +$5.04K
ROAD icon
125
Construction Partners
ROAD
$5.84B
$710K 0.16%
23,272
+19,290
+484% +$606K

Similar funds

Exane Derivatives's Q2 2021 Portfolio in Review

As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.

  • Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
  • Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
  • Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
  • Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
  • Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
  • Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.